Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA

Infect Control Hosp Epidemiol. 2006 Feb;27(2):185-7. doi: 10.1086/500625. Epub 2006 Feb 8.

Abstract

After the introduction of routine treatment for every nasal carrier of methicillin-resistant Staphylococcus aureus, active follow-up surveillance for nosocomial methicillin-resistant S. aureus infection was conducted for 5 years in an intensive care unit of a tertiary-care teaching hospital. There was a significant decrease in the incidence of nosocomial methicillin-resistant S. aureus infection during the later years of follow-up. Decolonization of nasal carriers of methicillin-resistant S. aureus is probably associated with such findings.

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents, Local / administration & dosage*
  • Anti-Infective Agents, Local / therapeutic use
  • Brazil
  • Chlorhexidine / administration & dosage*
  • Chlorhexidine / therapeutic use
  • Cross Infection / prevention & control
  • Humans
  • Infection Control / methods
  • Intensive Care Units*
  • Methicillin Resistance*
  • Mupirocin / administration & dosage*
  • Mupirocin / therapeutic use
  • Nose / microbiology*
  • Ointments
  • Staphylococcal Infections / epidemiology*
  • Staphylococcal Infections / prevention & control
  • Staphylococcus aureus* / drug effects

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents, Local
  • Ointments
  • Mupirocin
  • Chlorhexidine